Clincosm LogoSign in Get a demo

Type 2 Diabetes

Showing NaN - NaN of 71
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes Trial in Worldwide (Evolocumab, Placebo to Evolocumab)

Completed
Has Results
  • Hypercholesterolemia
  • +2 more
  • Evolocumab
  • Placebo to Evolocumab
  • Tuscumbia, Alabama
  • +65 more
Aug 2, 2018

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Sitagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Mesa, Arizona
  • +78 more
May 29, 2018

Type 2 Diabetes Trial in Puerto Rico, United States (INCB013739, Placebo comparator matching INCB013739, Metformin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +67 more
Feb 12, 2018

Type 2 Diabetes Trial in Miami (Cholecalciferol)

Completed
Has Results
  • Type 2 Diabetes
  • Miami, Florida
    Human Nutrition Laboratory, Florida International University
Nov 13, 2017

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Metformin XR, Dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +138 more
Mar 29, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide (HOE901/AVE0010), Insulin glargine (HOE901), Metformin

Completed
Has Results
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide (HOE901/AVE0010)
  • +2 more
  • Birmingham, Alabama
  • +235 more
Mar 31, 2017

Type 2 Diabetes Trial in Worldwide (Insulin glargine/lixisenatide Fixed Ratio Combination, Insulin glargine (HOE901),

Completed
Has Results
  • Type 2 Diabetes
  • Insulin glargine/lixisenatide Fixed Ratio Combination
  • +3 more
  • Phoenix, Arizona
  • +272 more
Mar 31, 2017

Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Placebo, Antidiabetic background therapy)

Completed
Has Results
  • Type 2 Diabetes
  • Lixisenatide (AVE0010)
  • +2 more
  • La Jolla, California
  • +82 more
Mar 21, 2017

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin, Thiazolidinedione (Pioglitazone))

Completed
Has Results
  • Type 2 Diabetes
  • Anniston, Alabama
  • +88 more
Jan 3, 2017

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Metformin XR)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +98 more
Jan 5, 2017

Type 2 Diabetes Trial in United States (Bydureon, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Anaheim, California
  • +28 more
Dec 5, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo-matching dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +328 more
Dec 2, 2016

Type 2 Diabetes Trial in Worldwide (Lixisenatide (AVE0010), Insulin glulisine QD, Insulin glulisine TID)

Completed
Has Results
  • Type 2 Diabetes
  • Lixisenatide (AVE0010)
  • +4 more
  • Sun City, Arizona
  • +198 more
Nov 4, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching Dapagliflozin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +297 more
Nov 10, 2016

Type 2 Diabetes Trial in United States (Bromocriptine mesylate)

Completed
  • Type 2 Diabetes
  • Bromocriptine mesylate
  • Phoenix, Arizona
  • +4 more
Aug 26, 2016

Type 2 Diabetes Trial in Miami (HM11260C, Placebo)

Completed
  • Type 2 Diabetes
  • Miami, Florida
    Hanmi pharmaceutical
Aug 8, 2016

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo matching with Dapagliflozin, Saxagliptin)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +66 more
May 18, 2016

Type 2 Diabetes Trial in Worldwide (ITCA 650 60 mcg/day, sitagliptin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +53 more
May 13, 2016

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Metformin IR)

Completed
Has Results
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +83 more
Mar 24, 2016

Type 1 Diabetes, Type 2 Diabetes Trial in United States (Technosphere Insulin Inhalation Powder)

No longer available
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Technosphere Insulin Inhalation Powder
  • Montgomery, Alabama
  • +13 more
Jan 19, 2016

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

Terminated
Has Results
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +587 more
Oct 15, 2015

Type 2 Diabetes Trial in United States (ITCA 650, ITCA )

Completed
  • Type 2 Diabetes
  • ITCA 650
  • ITCA placebo
  • Birmingham, Alabama
  • +121 more
Jul 28, 2015

Kidney Disease, Nephropathy, Type 2 Diabetes Trial in Puerto Rico, United States (losartan, lisinopril)

Terminated
Has Results
  • Kidney Disease
  • +2 more
  • Phoenix, Arizona
  • +30 more
May 8, 2015

Type 2 Diabetes Trial in Worldwide (MBX-102, Placebo, Actos)

Completed
  • Type 2 Diabetes
  • Jonesboro, Arkansas
  • +66 more
Apr 29, 2015

Type 2 Diabetes Trial in United States (Mitoglitazone, Pioglitazone, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Huntsville, Alabama
  • +23 more
Apr 6, 2015